Blood pressure-lowering efficacy of an olmesartan medoxomil/hydrochlorothiazide-based treatment algorithm in elderly patients (age ≥65 years) stratified by age, sex and race: subgroup analysis of a 12-week, open-label, single-arm, dose-titration study.

2011

Introduction: Hypertension is a leading risk factor for development of heart failure, stroke and renal disease in the elderly.

Keywords:

References

Citations